Stock Overview
Titan Biotech Share Price

Titan Biotech Share Price

437.15
+2.90 (0.67%)
11 Sep, 2026 • 03:30 PM
BSE: 524717 | Pharmaceuticals | Small Cap

Titan Biotech Annualised Returns

1 Year

196.48%Increase

3 Years

81.27%Increase

5 Years

43.92%Increase

10 Years

50.83%Increase

Titan Biotech Share Price Today


As of 14 Sep 2026, Titan Biotech share price is ₹437.2. The stock opened at ₹434.2 and had closed at ₹434.2 the previous day. During today’s trading session, Titan Biotech share price moved between ₹418.00 and ₹443.00, with an average price for the day of ₹430.50. Over the last 52 weeks, the stock has recorded a low of ₹143.00 and a high of ₹555.65. In terms of performance, Titan Biotech share price has increased by 12.8% over the past six months and has increased by 196.48% over the last year.

Titan Biotech Stock Performance

1W Return
0.71%
1M Return
9.78%
6M Return
18.31%
1Y Return
193.96%
3Y Return
519.10%
Today's High
₹443
Today's Low
₹418
52-Week High
₹555.65
52-Week Low
₹143
Prev. Close
₹434.25
Open
₹434.20
Face Value
₹2
Mkt Cap (Cr.)
₹1,806
PE Ratio
58.76

Titan Biotech Share Price Chart

Titan Biotech Company background

Founded in: 1992
Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food water, tissue culture laboratories and in the departments of microbiology botony in medical colleges/universities.The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.During 200607, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 200910.The Company has already started modernization of its existing plant, Building at Bhiwadi, Rajasthan for meeting international standards and quality improvement. With improvement in Building and Modernisation of Existing Plant, Company will be able to cater the needs of its customers in a better way and provide high quality products meeting international standards to its domestic as well as overseas customers.

Titan Biotech Financial Highlights


For the full year FY2026–2027, revenue reached ₹211.6 crore and profit touched at ₹27.45 crore.
Titan Biotech SIP Returns Calculator
5,000
Over the past
Total Investment of ₹3,00,000
Monthly SIP of 5,000 would have become 10,82,362 in 5 years with a gain of 7,82,362 (+260.79%)
Titan Biotech Fundamental

Market Cap (in crs)

1,806.24

Face Value

2

Turnover (in lacs)

107.91

Key Metrics

Qtr Change %
184.34% Gain from 52W Low
-1.7
Dividend yield 1yr %
Low in industry
0.1

Titan Biotech Key Financials

View more
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Loading chart...
Titan Biotech Result Highlights
  • Titan Biotech reported a 11.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 39.4%.
  • Its expenses for the quarter were down by 13.9% QoQ and up 29.0% YoY.
  • The net profit decreased 21.1% QoQ and increased 66.2% YoY.
  • The earnings per share (EPS) of Titan Biotech stood at 1.63 during Q4 FY 2025-26.

Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Titan Biotech Technical Analysis

Moving Averages Analysis
437.15
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
5 EMA
426.20
10 EMA
418.00
12 EMA
415.80
20 EMA
410.80
26 EMA
409.50
50 EMA
409.50
100 EMA
400.30
200 EMA
354.80

Delivery & Volume

Loading chart...

Day

100.00%

Week

100.00%

Month

100.00%

432.72
Pivot
Resistance
First Resistance
447.43
Second Resistance
457.72
Third Resistance
472.43
Support
First Support
422.43
Second support
407.72
Third Support
397.43
Relative Strength Index
61.26
Money Flow Index
77.09
MACD
6.31
MACD Signal
1.44
Average True Range
20.98
Average Directional Index
18.04
Rate of Change (21)
11.65
Rate of Change (125)
18.31
Compare

Titan Biotech Shareholding Pattern

Use arrow keys to navigate between tabs, Enter or Space to select, Home and End to go to first or last tab.
Promoter
55.8%
Public
44.2%
Titan Biotech Latest News
10 SEP 2026
07 SEP 2026
05 SEP 2026

You can easily buy Titan Biotech Ltd shares in Kotak Neo by opening a demat account and getting the KYC documents verified online.

The 52-week high and low of Titan Biotech Ltd share price is ₹555.65 and ₹143 as of 11/9/2026.

Please be aware that Titan Biotech Ltd stock prices are subject to continuous fluctuations due to various factors.